HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 2. Role of the substituents on the phenyl ring and nitrogen atoms of caproctamine.

Abstract
Continuing our studies on polyamine-based compounds of potential interest in the field of Alzheimer's disease therapeutics, we investigated the structure-activity relationships (SAR) of a lead compound (caproctamine, 3) identified in a previous work. In particular, we varied the substituents on the phenyl ring and on the nitrogen functions (both the amine and the amide), and studied the effects of such modifications on the inhibitory potency against isolated acetyl- and butyryl-cholinesterase (AChE and BChE). Moreover, the ability of selected compounds to reverse the d-tubocurarine-induced neuromuscular blockade and their antagonism toward muscarinic M(2) receptors in guinea pig left atrium were assayed. The most interesting SAR result was the identification of a relationship between the electronic characteristics of 2-substituents (measured by pK(a)) and the AChE inhibitory potency (pIC(50)) of tertiary amine compounds 6-12, which was confirmed by the invariance of the pIC(50) values of the corresponding methiodide derivatives 14-20. With regard to the biological profile, the most interesting compound was the N-ethyl-analogue of caproctamine (9), that showed pIC(50) values of 7.73 (+/-0.02) and 5.65 (+/-0.03) against AChE and BChE, respectively. The ability to increase the acetylcholine level was maintained in the functional assay (pAI(50) for reversing the neuromuscular blockade was 6.45 (+/-0.07)), as well as the ability to antagonize the M(2) receptors (pK(b) = 5.65 (+/-0.06)). Moreover, 9 showed a long duration of action as AChE inhibitor, an useful property in view of a possible development of this compound as a therapeutic agent.
AuthorsVincenzo Tumiatti, Michela Rosini, Manuela Bartolini, Andrea Cavalli, Gabriella Marucci, Vincenza Andrisano, Piero Angeli, Rita Banzi, Anna Minarini, Maurizio Recanatini, Carlo Melchiorre
JournalJournal of medicinal chemistry (J Med Chem) Vol. 46 Issue 6 Pg. 954-66 (Mar 13 2003) ISSN: 0022-2623 [Print] United States
PMID12620072 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • 6-(ethyl-(2-methoxybenzyl)amino)hexanoic acid (8-((6-(ethyl-(2-methoxybenzyl)amino)hexanoyl)methylamino)octyl)methylamide
  • Amides
  • Anisoles
  • Cholinesterase Inhibitors
  • Muscarinic Antagonists
  • Polyamines
  • Receptor, Muscarinic M2
  • Receptors, Muscarinic
  • caproctamine
  • Acetylcholinesterase
  • Butyrylcholinesterase
Topics
  • Acetylcholinesterase (chemistry, metabolism)
  • Amides (chemical synthesis, chemistry, pharmacology)
  • Animals
  • Anisoles (chemical synthesis, chemistry, pharmacology)
  • Atrial Function (drug effects)
  • Butyrylcholinesterase (chemistry)
  • Cholinesterase Inhibitors (chemical synthesis, chemistry, pharmacology)
  • Diaphragm (innervation)
  • Guinea Pigs
  • Heart Atria (drug effects)
  • Humans
  • In Vitro Techniques
  • Models, Molecular
  • Muscarinic Antagonists (chemical synthesis, chemistry, pharmacology)
  • Myocardial Contraction (drug effects)
  • Neuromuscular Blockade
  • Neuromuscular Junction (drug effects, physiology)
  • Polyamines (chemical synthesis, chemistry, pharmacology)
  • Rats
  • Receptor, Muscarinic M2
  • Receptors, Muscarinic (drug effects)
  • Stereoisomerism
  • Structure-Activity Relationship

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: